InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,310.25
(
0.81%
)
US TECH 100
18,313.60
(
0.92%
)
Dow Jones
39,204.17
(
0.36%
)
Brent Oil
81.45
(
0.17%
)
Bitcoin
68,300.01
(
0.55%
)
Post# of 251930
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119687
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: vinmantoo post# 251734

Tuesday, 05/07/2024 5:50:22 PM

Tuesday, May 07, 2024 5:50:22 PM

Post# of 251930

It seems like an over-reaction to me…

Quite so, IMO. The changes to ENTA’s guidance for expenses and data reporting are rather petty in the overall scheme of things. Still, biotech investors tend to cheer cost-cutting and react badly to cost increases. So, in that light ENTA’s selloff today is not too surprising.

ENTA regained half of today’s selloff by the close, so perhaps cooler heads prevailed in the afternoon.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up